论文信息 - EP02.04-001 Alectinib as Neoadjuvant Treatment in Surgically Resectable Stage III ALK-Positive NSCLC: ALNEO Phase II Trial (GOIRC-01-2020) - 字舞流文

EP02.04-001 Alectinib as Neoadjuvant Treatment in Surgically Resectable Stage III ALK-Positive NSCLC: ALNEO Phase II Trial (GOIRC-01-2020)

D. Galetta | F. Mazzoni | L. Boni | M. Tiseo | A. Delmonte | F. Passiglia | A. Leonetti | G. Guaitoli | S. Pilotto | C. Genova | A. Bearz | F. Gelsomino | L. Toschi | G. Pasello | L. Ampollini | G. Metro | M. Tognetto | L. Gnetti | F. Cecere | D. Cortinovis | H. S. Soto Parra | M. Migliorino | P. Bordi | R. Minari | A. Camerini | M. Verzè | E. Bria | D. Rocco